Viscosupplementation Devices - Medical Devices Pipeline Assessment, 2018
July 2018
79
About the Report
About the Report
Viscosupplementation Devices-Medical Devices Pipeline Assessment, 2018
Summary
GlobalData's Medical Devices sector report, Viscosupplementation Devices-Medical Devices Pipeline Assessment, 2018" provides an overview of Viscosupplementation Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Viscosupplementation Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Viscosupplementation Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Viscosupplementation Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Viscosupplementation Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date.
Products
Products
Ampio Pharmaceuticals Inc, Ampion; Ampio Pharmaceuticals Inc, Ampion - Hand Osteoarthritis; Anika Therapeutics Inc, Cingal; Anika Therapeutics Inc, Hyaluronic Acid - Synovial Joints; Anika Therapeutics Inc, MONOVISC; Anika Therapeutics Inc, MONOVISC - Hip; Anika Therapeutics Inc, ORTHOVISC-T; BioTime Inc, ReGlyde; Carticept Medical Inc, Agilus; Chi2Gel Ltd., Chi2Knee; Cocoon Biotech, Inc., Silk Hydrogel; Flex Biomedical Inc, Flex Polymer; Kalvista Pharmaceuticals Inc, ActaVisc; Kalvista Pharmaceuticals Inc, Hydros; Kalvista Pharmaceuticals Inc, Hydros TA; Kalvista Pharmaceuticals Inc, Hydros TA - Hip; KiOmed Pharma, Arthrovisc; Moebius Medical Ltd, MM-II; OPKO Health Inc, Enko 1; Shanghai Haohai Biological Technology Co Ltd, Thermal-Sensitive Chitosan Gel; Shin Poong PharmCo Ltd, HyalOne; Spring Therapeutics, CA-5136; University of Kansas, 3-D Colloidal Gel
Companies
Ampio Pharmaceuticals Inc
Anika Therapeutics Inc
BioTime Inc
Carticept Medical Inc
Chi2Gel Ltd.
Cocoon Biotech, Inc.
Flex Biomedical Inc
Kalvista Pharmaceuticals Inc
KiOmed Pharma
Moebius Medical Ltd
OPKO Health Inc
Shanghai Haohai Biological Technology Co Ltd
Shin Poong PharmCo Ltd
Spring Therapeutics
University of Kansas
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 5
2 Introduction 6
2.1 Viscosupplementation Devices Overview 6
3 Products under Development 7
3.1 Viscosupplementation Devices-Pipeline Products by Stage of Development 7
3.2 Viscosupplementation Devices-Pipeline Products by Segment 8
3.3 Viscosupplementation Devices-Pipeline Products by Territory 9
3.4 Viscosupplementation Devices-Pipeline Products by Regulatory Path 10
3.5 Viscosupplementation Devices-Pipeline Products by Estimated Approval Date 11
3.6 Viscosupplementation Devices-Ongoing Clinical Trials 12
4 Viscosupplementation Devices-Pipeline Products under Development by Companies 13
4.1 Viscosupplementation Devices Companies-Pipeline Products by Stage of Development 13
4.2 Viscosupplementation Devices-Pipeline Products by Stage of Development 14
5 Viscosupplementation Devices Companies and Product Overview 15
5.1 Ampio Pharmaceuticals Inc Company Overview 15
5.2 Anika Therapeutics Inc Company Overview 19
5.3 BioTime Inc Company Overview 25
5.4 Carticept Medical Inc Company Overview 27
5.5 Chi2Gel Ltd. Company Overview 28
5.6 Cocoon Biotech, Inc. Company Overview 29
5.7 Flex Biomedical Inc Company Overview 30
5.8 Kalvista Pharmaceuticals Inc Company Overview 31
5.9 KiOmed Pharma Company Overview 34
5.10 Moebius Medical Ltd Company Overview 35
5.11 OPKO Health Inc Company Overview 36
5.12 Shanghai Haohai Biological Technology Co Ltd Company Overview 37
5.13 Shin Poong PharmCo Ltd Company Overview 38
5.14 Spring Therapeutics Company Overview 39
5.15 University of Kansas Company Overview 40
6 Viscosupplementation Devices-Recent Developments 41
6.1 Jun 19, 2018: Anika Therapeutics Announces Top-Line Results from CINGAL 16-02 Clinical Trial in Knee Osteoarthritis 41
6.2 May 08, 2018: Smith & Nephew: Change of Directorate 41
6.3 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report 42
6.4 May 02, 2018: Anika Reports First Quarter 2018 Financial Results 44
7 Appendix 76
7.1 Methodology 76
7.2 About GlobalData 79
7.3 Contact Us 79
7.4 Disclaimer 79
List of Figure
1.2 List of Figures
Figure 1: Viscosupplementation Devices-Pipeline Products by Stage of Development 7
Figure 2: Viscosupplementation Devices-Pipeline Products by Segment 8
Figure 3: Viscosupplementation Devices-Pipeline Products by Territory 9
Figure 4: Viscosupplementation Devices-Pipeline Products by Regulatory Path 10
Figure 5: Viscosupplementation Devices-Pipeline Products by Estimated Approval Date 11
Figure 6: Viscosupplementation Devices-Ongoing Clinical Trials 12
List of Table
1.1 List of Tables
Table 1: Viscosupplementation Devices-Pipeline Products by Stage of Development 7
Table 2: Viscosupplementation Devices-Pipeline Products by Segment 8
Table 3: Viscosupplementation Devices-Pipeline Products by Territory 9
Table 4: Viscosupplementation Devices-Pipeline Products by Regulatory Path 10
Table 5: Viscosupplementation Devices-Pipeline Products by Estimated Approval Date 11
Table 6: Viscosupplementation Devices-Ongoing Clinical Trials 12
Table 7: Viscosupplementation Devices Companies-Pipeline Products by Stage of Development 13
Table 8: Viscosupplementation Devices-Pipeline Products by Stage of Development 14
Table 9: Ampio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 15
Table 10: Ampion-Product Status 15
Table 11: Ampion-Product Description 15
Table 12: Ampion-Hand Osteoarthritis-Product Status 16
Table 13: Ampion-Hand Osteoarthritis-Product Description 16
Table 14: Ampio Pharmaceuticals Inc-Ongoing Clinical Trials Overview 17
Table 15: Ampion-An Open Label Extension Study to Assess the Safety of Long-term Treatment with a 4 mL Intra-Articular Injection of Ampion in Adults with Pain Due to Severe Osteoarthritis of the Knee 18
Table 16: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 17: Cingal-Product Status 19
Table 18: Cingal-Product Description 20
Table 19: Hyaluronic Acid-Synovial Joints-Product Status 20
Table 20: Hyaluronic Acid-Synovial Joints-Product Description 20
Table 21: MONOVISC-Product Status 21
Table 22: MONOVISC-Product Description 21
Table 23: MONOVISC-Hip-Product Status 21
Table 24: MONOVISC-Hip-Product Description 22
Table 25: ORTHOVISC-T-Product Status 22
Table 26: ORTHOVISC-T-Product Description 22
Table 27: Anika Therapeutics Inc-Ongoing Clinical Trials Overview 23
Table 28: MONOVISC-Hip-Investigational Device Exemption (IDE) Phase III Study of MONOVISC to Treat Pain Caused by Osteoarthritis of the Hip 24
Table 29: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 25
Table 30: ReGlyde-Product Status 25
Table 31: ReGlyde-Product Description 26
Table 32: Carticept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 33: Agilus-Product Status 27
Table 34: Agilus-Product Description 27
Table 35: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 36: Chi2Knee-Product Status 28
Table 37: Chi2Knee-Product Description 28
Table 38: Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 39: Silk Hydrogel-Product Status 29
Table 40: Silk Hydrogel-Product Description 29
Table 41: Flex Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 42: Flex Polymer-Product Status 30
Table 43: Flex Polymer-Product Description 30
Table 44: Kalvista Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 45: ActaVisc-Product Status 31
Table 46: ActaVisc-Product Description 31
Table 47: Hydros-Product Status 32
Table 48: Hydros-Product Description 32
Table 49: Hydros TA-Product Status 32
Table 50: Hydros TA-Product Description 33
Table 51: Hydros TA-Hip-Product Status 33
Table 52: Hydros TA-Hip-Product Description 33
Table 53: KiOmed Pharma Pipeline Products & Ongoing Clinical Trials Overview 34
Table 54: Arthrovisc-Product Status 34
Table 55: Arthrovisc-Product Description 34
Table 56: Moebius Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
Table 57: MM-II-Product Status 35
Table 58: MM-II-Product Description 35
Table 59: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 60: Enko 1-Product Status 36
Table 61: Enko 1-Product Description 36
Table 62: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
Table 63: Thermal-Sensitive Chitosan Gel-Product Status 37
Table 64: Thermal-Sensitive Chitosan Gel-Product Description 37
Table 65: Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
Table 66: HyalOne-Product Status 38
Table 67: HyalOne-Product Description 38
Table 68: Spring Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 39
Table 69: CA-5136-Product Status 39
Table 70: CA-5136-Product Description 39
Table 71: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 40
Table 72: 3-D Colloidal Gel-Product Status 40
Table 73: 3-D Colloidal Gel-Product Description 40
Table 74: Glossary 78
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.